Eyenovia to change name to Hyperion DeFi, ticker to ‘HYPD’

Eyenovia (EYEN) announced that it has entered into a securities purchase agreement for a $50M private placement in public equity with institutional accredited investors. The company will use the funds to build a reserve of a token called HYPE, which is native to the decentralized digital asset exchange and Layer-1 blockchain, Hyperliquid (HYPE). “The PIPE Financing enables the company to acquire over 1,000,000 HYPE, enough to become one of the top globally active validators for Hyperliquid – and the first to be listed on Nasdaq. As part of the strategy, the company also intends to implement a HYPE staking program while securing the assets through a partnership with Anchorage Digital. This transaction aligns with the company’s vision of creating long-term value for shareholders by capitalizing on the global adoption of blockchain and digital innovation. In parallel with its new cryptocurrency treasury strategy, the company will continue to focus on its existing business, including development of the Gen-2 Optejet User Filled Device, which the company anticipates registering with the FDA by September 2025. The company continues to engage in commercial partnering discussions focused on the Optejet dispenser. The closing of the offering is expected to occur on or about June 20, 2025, subject to the satisfaction of customary closing conditions, with the Company also expected to change its name and ticker to ‘Hyperion DeFi (HYPD)’ and ‘HYPD’, respectively. Chardan is acting as the sole placement agent in connection with the transaction,” the company stated.